Hypoglycemia, Obesity
Conditions
Brief summary
This study will compare glucose and simple carbohydrate sensitivity. The hypothesis is that rapid emptying of high-glycemic index foods after Roux-En-Y gastric bypass (RYGB) causes reactive hypoglycemia. It is believed that the controlled release offered by an intact pylorus will be advantageous for long term results in bariatric surgery. This study can provide a scientific rationale, in a short duration of time, for why pylorus sparing surgery, such as the sleeve gastrectomy or duodenal switch, may offer therapeutic advantages, as compared to non-pyloric sparing surgery, namely the gastric bypass.
Detailed description
Clinical Trial Objective: The objective of this clinical trial is to determine whether an intact pylorus prevents reactive hypoglycemia following challenge with liquid glucose preparation and/or solid load made of refined flour product that is a simple carbohydrate. Clinical Trial Design: This is a prospective, non-randomized, clinical trial.
Interventions
None listed
Sponsors
Study design
Eligibility
Inclusion criteria
* The patient is greater than 18 years old; * The patient has a BMI \> 35; * Patient meets standards for bariatric surgery;
Exclusion criteria
* The patient has an incurable malignant or debilitating disease; * The patient has been diagnosed with a severe eating disorder; * The patient is currently pregnant (pregnancy test required for confirmation for those of child bearing years); * The patient is unable to comply with the study requirements, follow-up schedule, or to give valid informed consent
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| Mean Serum Glucose Levels | 30, 60, and 120 minutes at 6, 9, and 12 months post-operatively | Serum glucose levels measured to assess reactive hypoglycemia status |
| Reactive Hypoglycemia Status | 6 months, 9 months, 12 months post-op | Postoperative reactive hypoglycemia was defined as either * serum glucose \<60 mg/dL at least 1 hour after initiation of glucose tolerance testing * serum glucose decrease ≥100 mg/dL within 1 hour after initiation of glucose tolerance testing |
Secondary
| Measure | Time frame | Description |
|---|---|---|
| Insulin Resistance | 6, 9, and 12 months post-operatively | Measured by levels of post prandial insulin |
| Subjective Symptoms of Hypoglycemia During Glucose Tolerance Testing | 6, 9, and 12 months post-op | Subjective symptoms of hypoglycemia during glucose tolerance testing measured by patients' responses to a questionnaire about symptoms of Weakness, Nausea, Hunger, Headache, Dizziness, Diaphoresis graded on a yes/no response |
Countries
United States
Participant flow
Participants by arm
| Arm | Count |
|---|---|
| Pyloric-sparing Pyloric sparing: Sleeve Gastrectomy and Duodenal Switch | 39 |
| Non-pyloric Sparing Non-pyloric sparing: Roux-en-Y Gastric Bypass | 23 |
| Total | 62 |
Baseline characteristics
| Characteristic | Pyloric-sparing | Non-pyloric Sparing | Total |
|---|---|---|---|
| Age, Categorical <=18 years | 0 Participants | 0 Participants | 0 Participants |
| Age, Categorical >=65 years | 0 Participants | 0 Participants | 0 Participants |
| Age, Categorical Between 18 and 65 years | 39 Participants | 23 Participants | 62 Participants |
| Region of Enrollment United States | 39 participants | 23 participants | 62 participants |
| Sex: Female, Male Female | 24 Participants | 20 Participants | 44 Participants |
| Sex: Female, Male Male | 15 Participants | 3 Participants | 18 Participants |
Adverse events
| Event type | EG000 affected / at risk | EG001 affected / at risk |
|---|---|---|
| deaths Total, all-cause mortality | — / — | — / — |
| other Total, other adverse events | 8 / 39 | 2 / 23 |
| serious Total, serious adverse events | 5 / 39 | 3 / 23 |
Outcome results
Mean Serum Glucose Levels
Serum glucose levels measured to assess reactive hypoglycemia status
Time frame: 30, 60, and 120 minutes at 6, 9, and 12 months post-operatively
| Arm | Measure | Group | Value (MEAN) | Dispersion |
|---|---|---|---|---|
| Pyloric-sparing | Mean Serum Glucose Levels | 6 months - 60 minutes | 121.8 mg/dl | Standard Deviation 65.6 |
| Pyloric-sparing | Mean Serum Glucose Levels | 12 months - 60 minutes | 121.1 mg/dl | Standard Deviation 52.3 |
| Pyloric-sparing | Mean Serum Glucose Levels | 9 months - 30 minutes | 103.2 mg/dl | Standard Deviation 30.2 |
| Pyloric-sparing | Mean Serum Glucose Levels | 6 months - 120 minutes | 83.4 mg/dl | Standard Deviation 48.4 |
| Pyloric-sparing | Mean Serum Glucose Levels | 6 months - 30 minutes | 123.1 mg/dl | Standard Deviation 48.8 |
| Pyloric-sparing | Mean Serum Glucose Levels | 9 months - 120 minutes | 88.3 mg/dl | Standard Deviation 33.1 |
| Pyloric-sparing | Mean Serum Glucose Levels | 12 months - 30 minutes | 130.3 mg/dl | Standard Deviation 49.6 |
| Pyloric-sparing | Mean Serum Glucose Levels | 12 months - 120 minutes | 84.5 mg/dl | Standard Deviation 52.1 |
| Pyloric-sparing | Mean Serum Glucose Levels | 9 months - 60 minutes | 98.8 mg/dl | Standard Deviation 34.9 |
| Non-pyloric Sparing | Mean Serum Glucose Levels | 12 months - 120 minutes | 79.5 mg/dl | Standard Deviation 58.6 |
| Non-pyloric Sparing | Mean Serum Glucose Levels | 9 months - 60 minutes | 132.6 mg/dl | Standard Deviation 65.2 |
| Non-pyloric Sparing | Mean Serum Glucose Levels | 6 months - 30 minutes | 157.5 mg/dl | Standard Deviation 56.2 |
| Non-pyloric Sparing | Mean Serum Glucose Levels | 9 months - 30 minutes | 138 mg/dl | Standard Deviation 50.1 |
| Non-pyloric Sparing | Mean Serum Glucose Levels | 12 months - 30 minutes | 173.4 mg/dl | Standard Deviation 78.3 |
| Non-pyloric Sparing | Mean Serum Glucose Levels | 12 months - 60 minutes | 141.8 mg/dl | Standard Deviation 90.7 |
| Non-pyloric Sparing | Mean Serum Glucose Levels | 6 months - 120 minutes | 83.4 mg/dl | Standard Deviation 45.9 |
| Non-pyloric Sparing | Mean Serum Glucose Levels | 9 months - 120 minutes | 85.3 mg/dl | Standard Deviation 41.3 |
| Non-pyloric Sparing | Mean Serum Glucose Levels | 6 months - 60 minutes | 152.6 mg/dl | Standard Deviation 79.6 |
Reactive Hypoglycemia Status
Postoperative reactive hypoglycemia was defined as either * serum glucose \<60 mg/dL at least 1 hour after initiation of glucose tolerance testing * serum glucose decrease ≥100 mg/dL within 1 hour after initiation of glucose tolerance testing
Time frame: 6 months, 9 months, 12 months post-op
| Arm | Measure | Group | Value (NUMBER) |
|---|---|---|---|
| Pyloric-sparing | Reactive Hypoglycemia Status | 6 Month | 11 participants |
| Pyloric-sparing | Reactive Hypoglycemia Status | 9 Month | 4 participants |
| Pyloric-sparing | Reactive Hypoglycemia Status | 12 Month | 7 participants |
| Non-pyloric Sparing | Reactive Hypoglycemia Status | 6 Month | 6 participants |
| Non-pyloric Sparing | Reactive Hypoglycemia Status | 9 Month | 3 participants |
| Non-pyloric Sparing | Reactive Hypoglycemia Status | 12 Month | 7 participants |
Insulin Resistance
Measured by levels of post prandial insulin
Time frame: 6, 9, and 12 months post-operatively
| Arm | Measure | Group | Value (MEAN) | Dispersion |
|---|---|---|---|---|
| Pyloric-sparing | Insulin Resistance | 1 hour pp - 6 month | 13.7 pmol/L | Standard Deviation 11.7 |
| Pyloric-sparing | Insulin Resistance | 1 hour pp - 9 month | 6.4 pmol/L | Standard Deviation 3.2 |
| Pyloric-sparing | Insulin Resistance | 1 hour pp - 12 month | 10.9 pmol/L | Standard Deviation 9.3 |
| Pyloric-sparing | Insulin Resistance | 2 hours pp - 6 month | 3.8 pmol/L | Standard Deviation 2.5 |
| Pyloric-sparing | Insulin Resistance | 2 hours pp - 9 month | 2.6 pmol/L | Standard Deviation 2.3 |
| Pyloric-sparing | Insulin Resistance | 2 hours pp - 12 month | 4.8 pmol/L | Standard Deviation 12.4 |
| Non-pyloric Sparing | Insulin Resistance | 2 hours pp - 9 month | 4.2 pmol/L | Standard Deviation 4.9 |
| Non-pyloric Sparing | Insulin Resistance | 1 hour pp - 6 month | 21.2 pmol/L | Standard Deviation 16.4 |
| Non-pyloric Sparing | Insulin Resistance | 2 hours pp - 6 month | 3.9 pmol/L | Standard Deviation 6.7 |
| Non-pyloric Sparing | Insulin Resistance | 1 hour pp - 9 month | 20.9 pmol/L | Standard Deviation 25.1 |
| Non-pyloric Sparing | Insulin Resistance | 2 hours pp - 12 month | 6.6 pmol/L | Standard Deviation 12.3 |
| Non-pyloric Sparing | Insulin Resistance | 1 hour pp - 12 month | 16.7 pmol/L | Standard Deviation 14.6 |
Subjective Symptoms of Hypoglycemia During Glucose Tolerance Testing
Subjective symptoms of hypoglycemia during glucose tolerance testing measured by patients' responses to a questionnaire about symptoms of Weakness, Nausea, Hunger, Headache, Dizziness, Diaphoresis graded on a yes/no response
Time frame: 6, 9, and 12 months post-op
| Arm | Measure | Group | Value (NUMBER) |
|---|---|---|---|
| Pyloric-sparing | Subjective Symptoms of Hypoglycemia During Glucose Tolerance Testing | 12 Month - Nausea | 5 participants |
| Pyloric-sparing | Subjective Symptoms of Hypoglycemia During Glucose Tolerance Testing | 6 Month - Headache | 4 participants |
| Pyloric-sparing | Subjective Symptoms of Hypoglycemia During Glucose Tolerance Testing | 6 Month - Hunger | 4 participants |
| Pyloric-sparing | Subjective Symptoms of Hypoglycemia During Glucose Tolerance Testing | 9 Month - Hunger | 0 participants |
| Pyloric-sparing | Subjective Symptoms of Hypoglycemia During Glucose Tolerance Testing | 12 Month - Hunger | 2 participants |
| Pyloric-sparing | Subjective Symptoms of Hypoglycemia During Glucose Tolerance Testing | 9 Month - Headache | 3 participants |
| Pyloric-sparing | Subjective Symptoms of Hypoglycemia During Glucose Tolerance Testing | 12 Month - Headache | 4 participants |
| Pyloric-sparing | Subjective Symptoms of Hypoglycemia During Glucose Tolerance Testing | 6 Month - Dizziness | 10 participants |
| Pyloric-sparing | Subjective Symptoms of Hypoglycemia During Glucose Tolerance Testing | 9 Month - Dizziness | 1 participants |
| Pyloric-sparing | Subjective Symptoms of Hypoglycemia During Glucose Tolerance Testing | 12 Month - Dizziness | 0 participants |
| Pyloric-sparing | Subjective Symptoms of Hypoglycemia During Glucose Tolerance Testing | 6 Month - Sweating | 4 participants |
| Pyloric-sparing | Subjective Symptoms of Hypoglycemia During Glucose Tolerance Testing | 9 Month - Sweating | 0 participants |
| Pyloric-sparing | Subjective Symptoms of Hypoglycemia During Glucose Tolerance Testing | 12 Month - Sweating | 0 participants |
| Pyloric-sparing | Subjective Symptoms of Hypoglycemia During Glucose Tolerance Testing | 6 Month - Weakness | 6 participants |
| Pyloric-sparing | Subjective Symptoms of Hypoglycemia During Glucose Tolerance Testing | 9 Month - Weakness | 1 participants |
| Pyloric-sparing | Subjective Symptoms of Hypoglycemia During Glucose Tolerance Testing | 12 Month - Weakness | 2 participants |
| Pyloric-sparing | Subjective Symptoms of Hypoglycemia During Glucose Tolerance Testing | 6 Month - Nausea | 12 participants |
| Pyloric-sparing | Subjective Symptoms of Hypoglycemia During Glucose Tolerance Testing | 9 Month - Nausea | 2 participants |
| Non-pyloric Sparing | Subjective Symptoms of Hypoglycemia During Glucose Tolerance Testing | 6 Month - Weakness | 8 participants |
| Non-pyloric Sparing | Subjective Symptoms of Hypoglycemia During Glucose Tolerance Testing | 12 Month - Dizziness | 3 participants |
| Non-pyloric Sparing | Subjective Symptoms of Hypoglycemia During Glucose Tolerance Testing | 6 Month - Headache | 3 participants |
| Non-pyloric Sparing | Subjective Symptoms of Hypoglycemia During Glucose Tolerance Testing | 12 Month - Nausea | 6 participants |
| Non-pyloric Sparing | Subjective Symptoms of Hypoglycemia During Glucose Tolerance Testing | 9 Month - Nausea | 6 participants |
| Non-pyloric Sparing | Subjective Symptoms of Hypoglycemia During Glucose Tolerance Testing | 6 Month - Hunger | 3 participants |
| Non-pyloric Sparing | Subjective Symptoms of Hypoglycemia During Glucose Tolerance Testing | 6 Month - Sweating | 2 participants |
| Non-pyloric Sparing | Subjective Symptoms of Hypoglycemia During Glucose Tolerance Testing | 9 Month - Hunger | 2 participants |
| Non-pyloric Sparing | Subjective Symptoms of Hypoglycemia During Glucose Tolerance Testing | 9 Month - Weakness | 3 participants |
| Non-pyloric Sparing | Subjective Symptoms of Hypoglycemia During Glucose Tolerance Testing | 12 Month - Hunger | 1 participants |
| Non-pyloric Sparing | Subjective Symptoms of Hypoglycemia During Glucose Tolerance Testing | 9 Month - Sweating | 2 participants |
| Non-pyloric Sparing | Subjective Symptoms of Hypoglycemia During Glucose Tolerance Testing | 9 Month - Headache | 3 participants |
| Non-pyloric Sparing | Subjective Symptoms of Hypoglycemia During Glucose Tolerance Testing | 6 Month - Nausea | 8 participants |
| Non-pyloric Sparing | Subjective Symptoms of Hypoglycemia During Glucose Tolerance Testing | 12 Month - Headache | 3 participants |
| Non-pyloric Sparing | Subjective Symptoms of Hypoglycemia During Glucose Tolerance Testing | 12 Month - Sweating | 2 participants |
| Non-pyloric Sparing | Subjective Symptoms of Hypoglycemia During Glucose Tolerance Testing | 6 Month - Dizziness | 7 participants |
| Non-pyloric Sparing | Subjective Symptoms of Hypoglycemia During Glucose Tolerance Testing | 12 Month - Weakness | 6 participants |
| Non-pyloric Sparing | Subjective Symptoms of Hypoglycemia During Glucose Tolerance Testing | 9 Month - Dizziness | 4 participants |